Confirmation LDL-c lowering beyond current borders with non statin therapy is effective
Prof. Erik Stroes, Department of vascular medicine, AMC, Amsterdam, The Netherlands, talks about a great day for CV medicine and a step forward for future lipid research, after the presentation of the IMPROVE-IT trial results
Share this page with your colleagues and friends: